CUE logo

Cue Biopharma (CUE) Selling, General & Administrative Expenses

CUE Annual SG&A

$16.68 M
+$511.00 K+3.16%

31 December 2023

CUE Selling, General & Administrative Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CUE Quarterly SG&A

$2.87 M
-$644.00 K-18.34%

30 September 2024

CUE Quarterly SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CUE TTM SG&A

-$1.27 B
-$44.61 M-3.64%

30 September 2024

CUE TTM SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CUE Selling, General & Administrative Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+3.2%-18.3%-8066.9%
3 y3 years+13.8%-22.6%-7959.0%
5 y5 years+47.7%-22.6%-7959.0%

CUE Selling, General & Administrative Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-3.6%+3.2%-44.4%at low-74.5%at low
5 y5-year-3.6%+30.9%-44.4%at low-231.2%at low
alltimeall time-3.6%+3823.8%-44.4%+359.3%<-9999.0%at low

Cue Biopharma Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sept 2024
-
$2.87 M(-18.3%)
$15.17 M(-4.9%)
June 2024
-
$3.51 M(-16.1%)
$15.95 M(-4.4%)
Mar 2024
-
$4.19 M(-9.2%)
$16.69 M(+0.1%)
Dec 2023
$16.68 M(+3.2%)
$4.61 M(+26.4%)
$16.68 M(+5.7%)
Sept 2023
-
$3.65 M(-14.2%)
$15.77 M(+0.7%)
June 2023
-
$4.25 M(+1.7%)
$15.66 M(+3.1%)
Mar 2023
-
$4.18 M(+12.7%)
$15.19 M(-6.1%)
Dec 2022
$16.17 M(-6.6%)
$3.70 M(+5.0%)
$16.17 M(-5.5%)
Sept 2022
-
$3.53 M(-6.7%)
$17.11 M(-3.4%)
June 2022
-
$3.78 M(-26.6%)
$17.71 M(-2.7%)
Mar 2022
-
$5.16 M(+11.0%)
$18.21 M(+5.2%)
Dec 2021
$17.31 M(+18.1%)
$4.65 M(+12.6%)
$17.31 M(+7.0%)
Sept 2021
-
$4.13 M(-3.6%)
$16.18 M(+5.4%)
June 2021
-
$4.28 M(+0.6%)
$15.35 M(+2.6%)
Mar 2021
-
$4.25 M(+20.8%)
$14.97 M(+1.8%)
Dec 2020
$14.65 M
$3.52 M(+6.9%)
$14.70 M(+2.5%)
Sept 2020
-
$3.29 M(-15.5%)
$14.34 M(+3.9%)
DateAnnualQuarterlyTTM
June 2020
-
$3.90 M(-2.3%)
$13.80 M(+3.1%)
Mar 2020
-
$3.99 M(+26.2%)
$13.39 M(+4.2%)
Dec 2019
$12.74 M(+12.8%)
$3.16 M(+14.8%)
$12.84 M(-9.3%)
Sept 2019
-
$2.75 M(-21.0%)
$14.16 M(-1.0%)
June 2019
-
$3.49 M(+1.2%)
$14.30 M(+9.6%)
Mar 2019
-
$3.44 M(-23.0%)
$13.04 M(+15.4%)
Dec 2018
$11.30 M(+160.6%)
$4.47 M(+54.5%)
$11.30 M(+37.0%)
Sept 2018
-
$2.90 M(+29.8%)
$8.25 M(+29.2%)
June 2018
-
$2.23 M(+30.9%)
$6.38 M(+24.0%)
Mar 2018
-
$1.70 M(+20.0%)
$5.15 M(+18.8%)
Dec 2017
$4.33 M(+119.9%)
$1.42 M(+37.8%)
$4.33 M(+17.4%)
Sept 2017
-
$1.03 M(+3.4%)
$3.69 M(+12.3%)
June 2017
-
$996.00 K(+12.0%)
$3.29 M(+43.5%)
Mar 2017
-
$889.00 K(+14.4%)
$2.29 M(+63.4%)
Dec 2016
$1.97 M(+363.5%)
$777.00 K(+24.5%)
$1.40 M(+124.5%)
Sept 2016
-
$624.20 K
$624.20 K
Dec 2015
$425.10 K
-
-

FAQ

  • What is Cue Biopharma annual selling, general & administrative expenses?
  • What is the all time high annual SG&A for Cue Biopharma?
  • What is Cue Biopharma annual SG&A year-on-year change?
  • What is Cue Biopharma quarterly selling, general & administrative expenses?
  • What is the all time high quarterly SG&A for Cue Biopharma?
  • What is Cue Biopharma quarterly SG&A year-on-year change?
  • What is Cue Biopharma TTM selling, general & administrative expenses?
  • What is the all time high TTM SG&A for Cue Biopharma?
  • What is Cue Biopharma TTM SG&A year-on-year change?

What is Cue Biopharma annual selling, general & administrative expenses?

The current annual SG&A of CUE is $16.68 M

What is the all time high annual SG&A for Cue Biopharma?

Cue Biopharma all-time high annual selling, general & administrative expenses is $17.31 M

What is Cue Biopharma annual SG&A year-on-year change?

Over the past year, CUE annual selling, general & administrative expenses has changed by +$511.00 K (+3.16%)

What is Cue Biopharma quarterly selling, general & administrative expenses?

The current quarterly SG&A of CUE is $2.87 M

What is the all time high quarterly SG&A for Cue Biopharma?

Cue Biopharma all-time high quarterly selling, general & administrative expenses is $5.16 M

What is Cue Biopharma quarterly SG&A year-on-year change?

Over the past year, CUE quarterly selling, general & administrative expenses has changed by -$644.00 K (-18.34%)

What is Cue Biopharma TTM selling, general & administrative expenses?

The current TTM SG&A of CUE is -$1.27 B

What is the all time high TTM SG&A for Cue Biopharma?

Cue Biopharma all-time high TTM selling, general & administrative expenses is $18.21 M

What is Cue Biopharma TTM SG&A year-on-year change?

Over the past year, CUE TTM selling, general & administrative expenses has changed by -$1.29 B (-8066.92%)